HCPCS Level IIdrugActive
J9061
Inj, amivantamab-vmjw
BETOS: O1D
Effective: 2022-01-01
Description
Injection, amivantamab-vmjw, 2 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rybrevant
Manufacturer
Janssen Biotech, Inc.
HCPCS Dosage
2 MG
Billing Units
175.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.